5 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors

4. Travere Therapeutics, Inc. (NASDAQ:TVTX)

Edelman’s Stake Value: $384,422,000

Percentage of Joseph Edelman’s 13F Portfolio: 4.98%

Number of Hedge Fund Holders: 25

Travere Therapeutics, Inc. (NASDAQ: TVTX) is a California-based company engaged in the discovery and production of medical treatments for rare diseases. The company has secured the fourth rank on our list of the 10 best biotech stocks to buy according to Joseph Edelman’s Perceptive Advisors. 

On September 17, wealth management firm Canaccord lowered the price target on Travere Therapeutics, Inc. (NASDAQ: TVTX) from $45 to $42 and maintained a Buy rating. 

25 hedge funds out of the 873 tracked by Insider Monkey held stakes in Travere Therapeutics, Inc. (NASDAQ: TVTX) at the end of the second quarter of 2021, down from 27 in the preceding quarter.